"Monitoring, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumor antigen and other markers (often by RADIOIMMUNOASSAY), studies of cellular or humoral immunity in cancer etiology, IMMUNOTHERAPY trials, etc.
| Descriptor ID |
D015166
|
| MeSH Number(s) |
E01.370.225.812.505 E01.370.520.505 E05.200.812.505 E05.478.594.550
|
| Concept/Terms |
Monitoring, Immunologic- Monitoring, Immunologic
- Immunologic Monitoring
- Monitoring, Immunological
- Immunological Monitoring
- Immune Monitoring
- Monitoring, Immune
- Immunosurveillance
Radioimmunologic Monitoring- Radioimmunologic Monitoring
- Monitoring, Radioimmunological
- Radioimmunological Monitoring
- Monitoring, Radioimmunologic
|
Below are MeSH descriptors whose meaning is more general than "Monitoring, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Monitoring, Immunologic".
This graph shows the total number of publications written about "Monitoring, Immunologic" by people in this website by year, and whether "Monitoring, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2012 | 1 | 2 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Monitoring, Immunologic" by people in Profiles.
-
CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer. J Immunother Cancer. 2021 10; 9(10).
-
Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade. Neurosurgery. 2019 04 01; 84(4):945-953.
-
Establishment of a global virtual laboratory for transplantation: a symposium report. Transplantation. 2015 Feb; 99(2):381-4.
-
A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. J Transl Med. 2014 Mar 10; 12:63.
-
Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients. Pediatr Transplant. 2014 Feb; 18(1):79-86.
-
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies. J Transl Med. 2012 Nov 05; 10:218.
-
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. J Transl Med. 2012 Jul 09; 10:141.
-
Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clin Transplant. 2012 Nov-Dec; 26(6):826-32.
-
Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2007 Mar 27; 68(13):977-84.
-
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. Transplantation. 2006 Dec 27; 82(12):1649-52.